Skip to main content
S 2618 109th Congress Senate Health Access to health care Advertising Agriculture and Food Alternative medicine Australia Canada Commerce Communication in medicine Customs unions Deceptive advertising Dietary supplements Drug approvals Drug industry Drug interactions Drugs East Asia Europe European Union Evidence (Law)

Access to Medical Treatment Act

Introduced: April 7, 2006 See on congress.gov
This bill died when the 109th Congress ended
It never became law before the 109th Congress (2005–2006) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 7, 2006
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 7, 2006
Sponsor introductory remarks on measure. (CR S3390)
Apr 7, 2006
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Access to Medical Treatment Act - Gives an individual the right to be treated by a health care practitioner with any medical treatment that the individual desires, including a treatment that is not approved, certified, or licensed by the Secretary of Health and Human Services, if: (1) the practitioner has personally examined the individual and agrees to treat the individual; and (2) the administration of such treatment does not violate licensing laws and is within the scope of the practice of such practitioner.

Authorizes health care practitioners to provide any method of treatment to such an individual if certain requirements are met, including that: (1) there is no reason to conclude that such treatment will cause danger to the individual; and (2) the patient is informed in writing that such treatment has not been approved, certified, or licensed by the Secretary.

Requires a practitioner to report: (1) administering such treatment and discovering it to be a danger to an individual; and (2) the positive effects of an unconventional medical treatment for a life-threatening medical condition.

Allows an individual to introduce or deliver into interstate commerce, or to produce, transport, receive, or hold, a food, drug, device, or equipment solely for use in accordance with this Act if there have been no advertising claims made by the manufacturer, distributor, or seller with respect to a medical treatment.

Requires notification to the Secretary if: (1) an individual imports a shipment of a food, drug, device, or any other equipment; or (2) a manufacturer intends to deliver an unapproved drug, device, or other equipment into interstate commerce.

States that nothing in this Act shall in any way adversely affect the distribution or sale of dietary supplements.

What's happening now April 7, 2006

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2618: Access to Medical Treatment Act. 109th Congress. Open America. https://openamerica.io/bill/109-S-2618/
MLA
"S. 2618: Access to Medical Treatment Act." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-S-2618/.
Bluebook (legal)
S. 2618, 109th Cong. (2026), https://openamerica.io/bill/109-S-2618/.
Markdown link
[S. 2618: Access to Medical Treatment Act](https://openamerica.io/bill/109-S-2618/)
Report a problem